June 29, 2020 / 11:53 AM / 9 days ago

BRIEF-Altimmune Receives Award From U.S. Department Of Defense To Fund Phase 1/2 Clinical Trial Of T-Covid In Outpatients With Early Covid-19

June 29 (Reuters) - Altimmune Inc:

* ALTIMMUNE RECEIVES AWARD FROM U.S. DEPARTMENT OF DEFENSE TO FUND PHASE 1/2 CLINICAL TRIAL OF T-COVID™ IN OUTPATIENTS WITH EARLY COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below